AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
Supreme Court Tests Federal Reserve Independence Amid Trump’s Bid to Fire Lisa Cook 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
Indian Rupee Strengthens Sharply After U.S.-India Trade Deal Announcement 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
Asian Currencies Strengthen as Indian Rupee and Australian Dollar Rally 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Asian Markets Slide as Silver Volatility, Earnings Season, and Central Bank Meetings Rattle Investors 
IMF Forecasts Global Inflation Decline as Growth Remains Resilient 
Abbott Laboratories faces a criminal investigation by the Justice Department, after its recall of formulas due to complaints of bacterial infections exacerbated a shortage that began due to pandemic-induced supply chain issues.
The Justice Department was investigating conduct at Abbott’s plant in Sturgis, Michigan,
According to an Abbott spokesman, they are fully cooperating with the Justice Department without specifying what aspect of the company is under scrutiny.
In February 2022, Abbott, the biggest US supplier of baby formula, recalled Similac and other infant formula products produced at its Michigan facility after reports of bacterial infections in babies who had consumed products made there.
The US Food and Drug Administration found "shocking" results during an inspection, such as cracks in vital equipment, inadequate hand-washing, and evidence of previous bacterial contamination.
The plant has since reopened.
